openPR Logo
Press release

Drugs for Malaria Market Hit Stunning Double Digit CAGR +4% With Renowned Key Players Alvizia Healthcare Pvt. Ltd., Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc

11-30-2021 02:29 PM CET | Health & Medicine

Press release from: Report Consultant

Drugs for Malaria Market

Drugs for Malaria Market

The Drug for Malaria Market Doxycycline is an antibiotic that also can be used to prevent malaria. It is available in the United States by prescription only. It is sold under multiple brand names and it is also sold as a generic medicine. It is available in tablets, capsules, and an oral liquid formulation. Chloroquine phosphate. Chloroquine is the preferred treatment for any parasite that is sensitive to the drug. Artemisinin-based combination therapies. ACT is a combination of two or more drugs that work against the malaria parasite in different ways.

The global antimalarial drugs market accounted for $711,360 thousand in 2021 and is expected to reach $1,019,396 thousand by 2027, registering a CAGR of +4% from 2021 to 2027.

Doxycycline is an antibiotic. It's used to treat infections such as chest infections, skin infections, rosacea, dental infections, and sexually transmitted infections, as well as a lot of other rare infections. It can also be used to prevent malaria if you're traveling abroad. The Drugs for Malaria Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global Antiparasitic Drugs Industry presents a market overview, product details, classification, and market concentration.
key players profiled in the report:
• Alvizia Healthcare Pvt. Ltd.
• Bayer AG
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Ipca Laboratories Ltd.
• Merck & Co., Inc
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Zydus Cadila
Request a sample copy of this report @ Click here: –
https://www.reportconsultant.com/request_sample.php?id=94864

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Malaria is caused by the transmission of parasites belonging to the genus plasmodium. These parasites are transmitted through the bite of the female Anopheles mosquito, which then gets lodged into the liver. These parasites grow in the liver and multiply to further invade the red blood cells where these parasites mature and rupture the blood cell to form merozoites. These merozoites then invade other red blood cells, causing symptoms such as high fever, fatigue, dizziness, and others. Thus, malaria is highly fatal if left untreated for a long period of time.
Key Market Segments

By Drug Class
o Quinine
o Chloroquine
o Proguanil
o Mefloquine
o Pyrimethamine
o Others

By Distribution Channel
o Hospital Pharmacy
o Retail Pharmacy
o E-Commerce & Other Distribution Channel

Inquire Before Buying This Research Report: -
https://www.reportconsultant.com/enquiry_before_buying.php?id=94864

By Region
North America
Europe
Asia-Pacific
LAMEA
This report provides pin-point analysis for changing competitive dynamics
• It provides a forward-looking perspective on different factors driving or restraining market growth.
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow.
• It helps in understanding the key product segments and their future.
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors.
• It helps in making informed business decisions by having complete insights of the market and by making in-depth analyses of market segments.

Table of Contents:
Chapter 1: World Drugs for Malaria Market Overview
Chapter 2: Market Data Analysis
Chapter 3: Technical Data Analysis
Chapter 4: Government Policy and News
Chapter 5: World Drugs for Malaria Market Manufacturing Process
and Cost Structure
Chapter 6: Productions Supply Sales Demand Market Status and Forecast
Chapter 7: Key Manufacturers
Chapter 8: Up and Down Stream Industry Analysis Art Supplies
Chapter 9: Marketing Strategy
Chapter 10: 2021-2027 World Drugs for Malaria Market Development Trend
Analysis
Chapter 11: New Project Investment Feasibility Analysis

Rebecca Parker
(Report Consultant)
Contact No: +81-368444299
sales@reportconsultant.com
www.reportconsultant.com

About us:
Report Consultant is a prime destination for your business aptitude and analytical solutions because we provide qualitative and quantitative sources of information that are proficient to give one-stop solutions. We skillfully syndicate qualitative and quantitative research in exact proportions to have the best report, which not only gives the most recent insights but also assists you to grow.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drugs for Malaria Market Hit Stunning Double Digit CAGR +4% With Renowned Key Players Alvizia Healthcare Pvt. Ltd., Bayer AG, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc here

News-ID: 2479964 • Views: 151

More Releases from Report Consultant

Acute Kidney Injury (AKI) Disease Treatment Market Size and Forecast US$31.600 b …
Acute kidney failure can be deadly and requires serious therapy. Nonetheless, intense kidney disappointment might be reversible. On the off chance that you're generally healthy, you might recuperate ordinary or almost typical kidney function. The Global Acute Kidney Injury (AKI) Disease Treatment market was valued at US$29.612 billion in 2022 and is expected to grow at a CAGR of +1% over the forecast period to reach a market size of US$31.600
Uncomplicated Urinary Tract Infection Market to Key Players, Competitive Landsca …
Uncomplicated cystitis refers to a lower urinary tract infection (UTI) in one or the other men or non-pregnant ladies who are generally sound. Confounded cystitis, then again, is related with hazard factors that expand the danger of disease or the danger of bombing anti-microbial treatment. Uncomplicated Urinary Tract Infection in a sound, non-pregnant, pre-menopausal female patient with physically and practically ordinary urinary parcel. Confounded UTI - contamination related with factors expanding
Spinal Implants & Surgery Devices Market Key Players, Competitive Landscape, Rev …
A spinal implant is a device used to soothe back torment and oversee messes connected with the spine. The spinal section, otherwise called the vertebrae, is included 33 bones that empower the body to stand upstanding, sit, and twist. Spinal implants are utilized to settle the shaky spine brought about by injury or by slipped vertebrae spondylolisthesis starting from degenerative intervertebral circles. The Global Spinal Implants and Surgery Devices Market is
Smart Orthopedic Implants Market Size and Forecast USD 8.09 Billion at a CAGR of …
Smart implants are implantable devices that provide not only therapeutic benefits but also have diagnostic capabilities. Smart implants can enable personalized medicine, optimize care for individual patients and improve outcomes while reducing costs. An orthopedic implant is a manufactured device designed to replace a joint, bone, or cartilage due to damage or deformity such as from breaking a leg, losing a limb, or a congenital defect. The Smart Orthopedic Implants

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning